Industry News
Specialized Telerobotic System Designed To Treat Bladder Cancer
Apr 04, 2013
Although bladder cancer is the sixth most common form of cancer in the U.S. and the most expensive to treat, the basic method that doctors use to treat it hasn't changed much in more than 70 years. An interdisciplinary collaboration of engineers and doctors at Vanderbilt and Columbia Universities intends to change that situation dramatically... Read More
Charity Warns 6,500 Bowel Cancer Patients Will Lose Out On Vital Medicines
Apr 04, 2013
As many as 6,500 (6,427(1)) new patients a year in England could be denied access to life-extending medicines when the Government's special Cancer Drugs Fund comes to an end at the beginning of next year, according to new research by the charity Beating Bowel Cancer... Read More
More Realistic Tumor Growth And Response To Anti-Cancer Drugs Using Polymer Scaffolds
Apr 04, 2013
Porous polymer scaffolds fabricated to support the growth of biological tissue for implantation may hold the potential to greatly accelerate the development of cancer therapeutics... Read More
Particle-Payload Delivery Systems Sneak Drugs Past Cancer's Defenses
Apr 04, 2013
DNA, siRNA and miRNA can reprogram cancer cells - that is, if these nucleic acids could cross through the cell membrane. A University of Colorado Cancer Center study published in the journal Therapeutic Delivery shows that cholesterol "rafts" can shepherd genetic payloads into cancer cells... Read More
Risk Factors For Blood Clots In Pregnant And Postnatal Women
Apr 04, 2013
Women who have suffered a still birth or have medical conditions including varicose veins, inflammatory bowel disease (IBD) or heart disease are at greater risk of developing dangerous blood clots after giving birth, a study has revealed... Read More
AMD Blindness May Be Avoidable With Anti-Cholesterol Drugs
Apr 03, 2013
New research that links the causes of age-related macular degeneration (AMD) with clogged arteries suggests anti-cholesterol drugs may halt the eye disease, the leading cause of blindess among older people in the US. In the 2 April issue of Cell Metabolism, senior investigator Rajendra S. Apte, of the Washington University School of Medicine in St... Read More
Arrival Of Next-Generation Proton Therapy Tool Increases Precision, Expands Types Of Tumors That Can Be Treated At Illinois Center
Apr 03, 2013
Pencil beam scanning boosts accuracy, further minimizes radiation delivered to healthy tissue One of the most precise tools in the fight against cancer is now available to patients in the Midwest... Read More
Surgical Removal Of Lung Metastases In Breast Cancer Patients May Improve Overall Survival
Apr 03, 2013
Results Differ from Previous Research Showing Surgery Was Not a Viable Option Patients with primary breast cancer that has spread to the lungs may live longer if the lung metastases are surgically removed, according to a study published in the April 2013 issue of The Annals of Thoracic Surgery... Read More
Therapeutic Target For Prostate Cancer Provided By Newly Identified Tumor Suppressor
Apr 03, 2013
Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have identified how an enzyme called PKCζ suppresses prostate tumor formation. The finding, which also describes a molecular chain of events that controls cell growth and metastasis, could lead to novel ways to control disease progression. Working in close collaboration, the labs of Maria T. Diaz-Meco, Ph.D... Read More
Delay Between Prostate Cancer Diagnosis And Treatment Longer For African Americans
Apr 03, 2013
African American men on average wait a week longer than their Caucasian counterparts between the initial diagnosis of prostate cancer and treatment, according to University of North Carolina researchers... Read More
Previous Page Next Page